{
    "Trade/Device Name(s)": [
        "BD MAX Enteric Parasite Panel",
        "BD MAX System"
    ],
    "Submitter Information": "Becton, Dickinson and Company",
    "510(k) Number": "K220193",
    "Predicate Device Reference 510(k) Number(s)": [
        "K143648"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "PCH",
        "OOI"
    ],
    "Summary Letter Date": "January 21, 2022",
    "Summary Letter Received Date": "January 24, 2022",
    "Submission Date": "January 21, 2022",
    "Regulation Number(s)": [
        "21 CFR 866.3990"
    ],
    "Regulation Name(s)": [
        "Gastrointestinal Microorganism Multiplex Nucleic Acid-Based Assay"
    ],
    "Analyte Class(es)": [
        "parisitology",
        "microbiology",
        "genetic molecular"
    ],
    "Analyte(s)": [
        "Giardia lamblia",
        "Cryptosporidium hominis",
        "Cryptosporidium parvum",
        "Entamoeba histolytica"
    ],
    "Specimen Type(s)": [
        "Unpreserved stool",
        "10% formalin-fixed stool",
        "FecalSwab specimen"
    ],
    "Specimen Container(s)": [
        "Plastic container with lid prefilled 15 ml of media",
        "FecalSwab transport medium tube",
        "BD MAX sample buffer tube"
    ],
    "Instrument(s)/Platform(s)": [
        "BD MAX System"
    ],
    "Method(s)/Technology(ies)": [
        "Real-time PCR",
        "Fluorogenic gene-specific hybridization probe detection",
        "Hydrolysis probe (TaqMan) detection",
        "Automated sample preparation and nucleic acid extraction"
    ],
    "Methodologies": [
        "Molecular diagnostics",
        "Nucleic acid amplification",
        "Automated real-time PCR"
    ],
    "Submission Type(s)": [
        "Panel",
        "Assay",
        "Instrument",
        "Automated system",
        "Reagent",
        "Cartridge",
        "Consumable",
        "Specimen collection device"
    ],
    "Document Summary": "FDA 510(k) summary for BD MAX Enteric Parasite Panel using automated real-time PCR for qualitative detection of Giardia lamblia, Cryptosporidium hominis/parvum, and Entamoeba histolytica from stool and FecalSwab specimens",
    "Indications for Use Summary": "Aids in differential diagnosis of gastrointestinal infection by direct qualitative detection of enteric parasitic pathogens (Giardia lamblia, Cryptosporidium hominis/parvum, Entamoeba histolytica) from stool and FecalSwab specimens using real-time PCR on the BD MAX System, in conjunction with clinical evaluation",
    "fda_folder": "Microbiology"
}